Camera-based radiotherapy dosimetry using dual-material 3D printed scintillator arrays.

PURPOSE AND OBJECTIVE: To describe a methodology for the dual-material fused deposition modeling (FDM) 3D printing of plastic scintillator arrays, to characterize their light output under irradiation using an sCMOS camera, and to establish a methodology for the dosimetric calibration of planar array geometries. MATERIALS AND METHODS: We have published an investigation into the fabrication and characterization of single element FDM printed scintillators intending to produce customizable dosimeters for radiation therapy applications. 1 This work builds on previous investigations by extending the concept to the production of a high-resolution (scintillating element size 3 × 3 × 3 mm3 ) planar scintillator array. The array was fabricated using a BCN3D Epsilon W27 3D printer and composed of polylactic acid (PLA) filament and BCF-10 plastic scintillator. The array's response was initially characterized using a 20 × 20 cm2 6 MV photon field with a source-to-surface (SSD) distance of 100 cm and the beam incident on the top of the array. The light signals emitted under irradiation were imaged using 200 ms exposures from a sCMOS camera positioned at the foot of the treatment couch (210 cm from the array). The collected images were then processed using a purpose-built software to correct known optical artefacts and determine the light output for each scintillating element. The light output was then corrected for element sensitivity and calibrated to dose using Monte Carlo simulations of the array and irradiation geometry based on the array's digital 3D print model. To assess the accuracy of the array calibration both a 3D beam and a clinical VMAT plan were delivered. Dose measurements using the calibrated array were then compared to EBT3 GAFChromic film and OSLD measurements, as well as Monte Carlo simulations and TPS calculations. RESULTS: Our results establish the feasibility of dual-material 3D printing for the fabrication of custom plastic scintillator arrays. Assessment of the 3D printed scintillators response across each row of the array demonstrated a nonuniform response with an average percentage deviation from the mean of 2.1% ± 2.8%. This remains consistent with our previous work on individual 3D printed scintillators which showed an average difference of 2.3% and a maximum of 4.0% between identically printed scintillators.1 Array dose measurements performed following calibration indicate difficulty in differentiating the scintillator response from ambient background light contamination at low doses (<20-25 cGy) and dose rates (≤100 MU/min). However, when analysis was restricted to exclude dose values less than 10% of the Monte Carlo simulated max dose the average absolute percentage dose difference between Monte Carlo simulation and array measurement was 5.3% ± 4.8% for the fixed beam delivery and 5.4% ± 5.2% for the VMAT delivery CONCLUSION: In this study, we developed and characterized a 3D printed array of plastic scintillators and demonstrated a methodology for the dosimetric calibration of a simple array geometry.

Fabrication and characterization of a stemless plastic scintillation detector.

PURPOSE: To fabricate a stemless plastic scintillation detector (SPSD) and characterize its linearity and reproducibility, and its dependence on energy and dose per pulse; and to apply it to clinical PDD and output factor measurements. METHODS: An organic bulk heterojunction photodiode was fabricated by spin coating a blend of P3HT and PCBM onto an ITO-coated glass substrate and depositing aluminum top contacts. Eljen scintillators (~5 × 5 × 5 mm3 ; EJ-204, EJ-208, and EJ-260) or Saint-Gobain scintillators (~3 × 3 × 2 mm3 ; BC-400 and BC-412) were placed on the opposite side of the glass using a silicone grease (optical coupling agent) creating the SPSD. Energy dependence was measured by using 100, 180, and 300 kVp photon beams from an orthovoltage treatment unit (Xstrahl 300) and 6 and 10 MV photons from a Varian TrueBeam linear accelerator. Linearity, dose per pulse dependence, output factors, and PDDs were measured using a 6 MV photon beam. PDDs and output factors were compared to ion chamber measurements. A control device was fabricated by substituting polystyrene (PS) for the P3HT/PCBM layer. No photocurrent should be generated in the control device and so any current measured is due to Compton current in the electrodes, wires, and surroundings from the irradiation. Output factors were corrected by subtracting the signal measured using the control device from the photodiode measured signal to yield the photocurrent. RESULTS: Each SPSD had excellent linearity with dose having an r2 of 1 and sensitivities of 1.07 nC/cGy, 1.04 nC/cGy, 1.00 nC/cGy and 0.10 nC/cGy, and 0.10 nC/cGy for EJ-204, EJ-208, EJ-260 (5 × 5 × 5 mm3 volumes), BC-400, and BC-412 (3 × 3 × 2 mm3 volumes), respectively. No significant dose per pulse dependence was measured. Output factors matched within 1% for the large scintillators for field sizes of 5 × 5 cm2 to 25 × 25 cm2 , but there was a large under-response at field sizes below 3 × 3 cm2 . After correcting the signal of the small scintillators by subtracting the current measured using the PS control, the output factors agreed with the ion chamber measurements within 1% from field sizes 1 × 1 cm2 to 20 × 20 cm2 . The impact of Cerenkov emissions in the scintillator was effectively corrected with a simple reflective coating on the scintillator. In comparison to a 6 MV photon beam, the large scintillator SPSDs exhibited 37%, 52%, and 73% of the response at energies 100 kVp, 180 kVp and 300 kVp, respectively. CONCLUSION: The principle of the SPSD was demonstrated. Devices had excellent linearity, reproducibility, and no significant dose per pulse dependence, and a simple reflective coating was sufficient to correct for Cerenkov emissions from within the scintillator. The devices demonstrated similar energy dependence to other scintillator detectors used in a radiotherapy setting.

Radiochromic film in vivo dosimetry predicts early the risk of acute skin toxicity for brachytherapy partial breast irradiation.

Brachytherapy accelerated partial breast irradiation (APBI) is well tolerated, but reported acute toxicities including moist desquamation rates range from 7% to 39%. Moist desquamation is correlated to long-term skin toxicity and high skin dose is the main risk factor. This study uses radiochromic films for in vivo skin dosimetry of low dose rate (LDR) APBI brachytherapy and prediction of skin toxicity. Patients participating in a clinical trial assessing skin toxicity of LDR seed brachytherapy were included in this study. Following the seed implantation procedure, patients were asked to wear a customized oval shaped radiochromic film on the skin projection of the planned target volume (PTV) for 24 h. Exposed films were collected, and maximum point doses were measured. In addition, maximum doses to a small skin volume (D0.2cc) were calculated on the pre- and post-implant CT-scan. Acute skin toxicities (redness, pigmentation, induration and dermatitis) were scored by the treating physician for 2 months during follow-up visits. Skin dose measurements and acute toxicity were available for 18 consecutive patients. The post-implant calculated maximum skin doses (D0.2cc), 60.8 Gy (SD ± 41.0), were on average 30% higher than those measured in vivo (Dmax-film), 46.6 Gy (SD ± 19.3), but those values were highly significantly correlated (Spearman's rho 0.827, p < 0.001). Also, dermatitis and induration were significantly correlated with higher in vivo measured and post-implant calculated skin dose. Pre-implant dosimetry was not correlated with measured or post-implant skin dose or side effects. Radiochromic films can reliably diagnose excess dose to the skin during the first 24 h and predict skin toxicity, which enables preventative measures. Trial registration: Nederlands Trial Register (www.trialregister.nl), NTR6549, the trial was registered prospectively on 27 June 2017. ABR number: NL56210.078.16.

Characterization of novel 3D printed plastic scintillation dosimeters.

We propose a new methodology for the fabrication and evaluation of scintillating detector elements using a consumer grade fusion deposition modeling (FDM) 3D printer. In this study we performed a comprehensive investigation into both the effects of the 3D printing process on the scintillation light output of 3D printed plastic scintillation dosimeters (PSDs) and their associated dosimetric properties. Fabrication properties including print variability, layer thickness, anisotropy and extrusion temperature were assessed for 1 cm3 printed samples. We then examined the stability, dose linearity, dose rate proportionality, energy dependence and reproducibility of the 3D printed PSDs compared to benchmarks set by commercially available products. Experimental results indicate that the shape of the emission spectrum of the 3D printed PSDs do not show significant spectral differences when compared to the emission spectrum of the commercial sample. However, the magnitude of scintillation light output was found to be strongly dependent on the parameters of the fabrication process. Dosimetric testing indicates that the 3D printed PSDs share many desirable properties with current commercially available PSDs such as dose linearity, dose rate independence, energy independence in the MV range, repeatability, and stability. These results demonstrate that not only does 3D printing offer a new avenue for the production and manufacturing of PSDs but also allows for further investigation into the application of 3D printing in dosimetry. Such investigations could include options for 3D printed, patient-specific scintillating dosimeters that may be used as standalone dosimeters or incorporated into existing 3D printed patient devices (e.g. bolus or immobilization) used during the delivery of radiation therapy.

Energy-dependent OAR sparing and dose conformity for total marrow irradiation of obese patients.

PURPOSE: To investigate the effect on target coverage and organs at risk sparing by using 10 versus 6 MV for VMAT total marrow irradiation of obese patients. METHODS AND MATERIALS: Twenty-six total marrow irradiation, TMI, treatment plans delivered between December 2014 and June 2017 were reviewed and 10 were chosen for replanning based on patient characteristics and plan metrics. Beam geometry and isocenter placement were conserved, energy was changed from 6 to 10 MV and plans were reoptimized. Resulting dose distributions were compared to original plans to evaluate any potential advantage of choosing one energy over the other. RESULTS: Target coverage and total monitor units were consistent between the 6 and 10 MV plans when averaged over all ten patients. Improvement in the conformity index (-11.0%, P = 0.009) when using 10 MV was statistically significant compared to the 6 MV plans. Volumes of normal tissue receiving 50%, 75%, and 90% Rx all decreased for the 10 MV plans compared to the original 6 MV plans. The mean dose to individual OARs decreased significantly for all investigated structures except for the lenses, oral cavity, and genitalia. The largest decreases in Dmean were found for the rectum (22.4%, P = 0.004) and bladder (18.1%, P = 0.005). The three highest priorities for sparing during plan optimization (lungs, liver, and heart), showed decreases of 7.6%, 16.1%, and 13.0%. CONCLUSIONS: Use of a higher energy 10 MV beam provided similar dose to target while achieving increased OAR and normal tissue sparing for the patients reviewed in this study.